MEDCL MedinCell S.A.
23.06EUR+3.87%Mkt Cap: 900.40M $P/E: —1d ago
MedinCell S.A. engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France. Th…
Industry Peers
Biotechnology$127.54BUSDP/E 29.3
$81.13BUSD
$74.79BUSDP/E 18.0
$57.11BUSDP/E 34.8
$55.24BUSDP/E 36.1
$44.51BUSD
$41.63BUSDP/E 17.7
$41.14BUSDP/E 64.7
$32.74BUSDP/E 30.1
$29.42BUSDP/E 37.1
$25.84BUSD
$24.53BUSD
$24.01BUSDP/E 30.3
$23.13BUSDP/E 14.5
$22.67BUSD
$21.61BUSDP/E 29.3
$15.32BUSDP/E 16.2
$15.01BUSDP/E 17.5
$14.58BUSDP/E 18.6
$13.78BUSD
| Headline | Source | Time |
|---|---|---|
Yesterday | ||
IIdeal Investisseur | ||
Older | ||
IIdeal Investisseur | ||
IIdeal Investisseur | ||
KKohen Avocats | ||
TToulÉco | ||
PPresse Agence | ||
LLa Gazette du Midi | ||
MMyPharma Editions | ||
PPresse Agence | ||